Latest News & Features
Americas
California-based pharmaceutical company Prometheus Laboratories has asked the US Court of Appeals for the Federal Circuit to reinstate a patent covering its irritable bowel syndrome drug Lotronex. 4 June 2015
Europe
To opt out or not, that is the question for patentees under the new Unified Patent Court system, say Paul England and Anja Lunze of Taylor Wessing, in the third installment of a regular column on the unitary patent and UPC. 4 June 2015
Americas
Robert Licht, former senior vice president of pharmaceutical company Biogen, has joined law firm Choate Hall & Stewart as a partner in the firm’s life sciences group. 4 June 2015
Asia
The Indian Patent Office has reportedly rejected an application covering US company Abraxis BioScience’s cancer drug Abraxane. 3 June 2015
Americas
Novartis has sued Apotex at the US District Court for the District of New Jersey to protect its drug Zometa from generic competition. 2 June 2015
Americas
Law firm Mayer Brown has hired Mark Mansour as partner in its Washington, DC office. 2 June 2015
article
The English Court of Appeal has said pharmaceutical company Warner-Lambert has a viable argument that Actavis indirectly infringed a second medical use patent covering Warner’s drug Lyrica. 1 June 2015
Americas
A US appeals court has ruled that Actavis’s attempt to force Alzheimer’s patients to switch from one medication to another before generic companies entered the market was anti-competitive. 1 June 2015
Americas
Israel-based pharmaceutical company Teva will have to fork out $1.2 billion after a long-running dispute with the US Federal Trade Commission over a controversial ‘pay-for-delay’ case was settled. 29 May 2015
Asia
If the proposals for the TPP trade agreement are accepted, a significant change in the patent law and practice of Vietnam would follow, as Tran Manh Hung and Bui Phuong of BMVN describe. 28 May 2015